Related Experiment Video
Updated: Jan 8, 2026
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Enhancing Remyelination by Blockade of Astrocytic P2X1 Receptors Signaling in Cuprizone-Induced Demyelination Mouse
Zhengtao Xu1, Tianyu Gao1, Hua Xie1
1Key Laboratory of Brain, Cognition and Education Sciences of Ministry of Education; Institute for Brain Research and Rehabilitation, Guangdong Key Laboratory of Mental Health and Cognitive Science, and Center for Studies of Psychological Application, South China Normal University, Guangzhou, China.
Reactive astrocytes in demyelinating diseases upregulate P2X1 receptors, inhibiting remyelination. Blocking this P2X1 receptor pathway in astrocytes promotes myelin repair and offers a potential therapeutic target for multiple sclerosis.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Demyelinating diseases like multiple sclerosis (MS) involve myelin and oligodendrocyte damage, leading to neurological dysfunction.
- Current MS therapies offer limited benefits for disease progression, highlighting the need for pro-myelination strategies.
- Reactive astrocytes play a complex role in demyelination and remyelination, but the mechanisms are not fully understood.
Purpose of the Study:
- To investigate the role of P2 purinergic receptor X1 (P2X1) in reactive astrocytes during demyelination and remyelination.
- To determine if targeting P2X1 signaling in astrocytes can promote myelin repair.
Main Methods:
- Used a cuprizone-induced demyelination mouse model.
- Administered P2X1 receptor antagonist NF449 to block P2X1 signaling.
- Generated astrocyte-specific conditional knockout mice for P2X1.
- Utilized in vitro astrocyte cultures and oligodendrocyte precursor cell (OPC) differentiation assays.
Main Results:
- Reactive astrocytes in demyelination models showed increased P2X1 expression.
- Pharmacological blockade or genetic knockout of P2X1 in astrocytes accelerated remyelination and altered oligodendrocyte production.
- Conditioned medium from P2X1-overexpressing astrocytes inhibited OPC differentiation in vitro.
Conclusions:
- Aberrant P2X1 signaling in reactive astrocytes acts as an endogenous inhibitor of remyelination.
- Blocking P2X1 signaling in astrocytes presents a promising therapeutic strategy for promoting myelin repair in demyelinating diseases.
